All opportunities
Internal Opportunity
Hybrid – U.S.-based, with regular engagement across major U.S. health systems, integrated delivery networks, and payor/PBM organisations.
Full-time, Executive Leadership Position.
Vice President / Executive
Pharmaceuticals / Biopharmaceuticals

Vice President, Health System Access & Commercial Contracting

Employer
Johnson & Johnson Innovative Medicine
Industry
Pharmaceuticals / Biopharmaceuticals
Location
United States – national market remit; physical office location not specified
Country
United States – confirm actual employing location
Work arrangement
Full-time, Executive Leadership Position.
Employment type
Hybrid – U.S.-based, with regular engagement across major U.S. health systems, integrated delivery networks, and payor/PBM organisations.
Seniority
Vice President / Executive
Department
U.S. Market Access / Health System Access & Commercial Contracting
Application status
Accepting applications
Closes in–d –h –m –s· Wednesday, 25 November 2026 at 00:00 (UTC)

Your application is received by Westbridge for review. We do not automatically forward materials to an employer.

About the role

This executive position is centred on expanding health-system access and commercial contracting capabilities across Johnson & Johnson Innovative Medicine's U.S. market.

The successful executive will be responsible for developing market access strategies and commercial agreements with major U.S. health systems, integrated delivery networks, and payor/PBM organisations.

A significant part of the remit involves navigating inpatient and outpatient reimbursement pathways for CAR-T and advanced oncology therapies, including pass-through payments and innovative risk-sharing arrangements.

The role also requires close collaboration with Health Economics & Outcomes Research (HEOR), Medical Affairs, and Corporate Pricing to address Inflation Reduction Act (IRA) policies and Medicaid best-price considerations.

Company overview

Johnson & Johnson Innovative Medicine. The supplied briefing identifies the organization as part of a Fortune 50 enterprise. No further company description was included in the materials.

Key responsibilities

Lead U.S. market access strategy and develop value-based contracting models with major health systems, integrated delivery networks (IDNs), and payor/PBM accounts.

Oversee inpatient and outpatient reimbursement pathways, pass-through payments, and risk-sharing agreements for CAR-T and advanced oncology therapies.

Develop and manage commercial contracting strategies with major U.S. healthcare organisations.

Collaborate with Health Economics & Outcomes Research (HEOR), Medical Affairs, and Corporate Pricing teams.

Address Inflation Reduction Act (IRA) policy implications and Medicaid best-price considerations within market access strategy.

Candidate profile

An experienced commercial market access executive with a background in U.S. health-system contracting, payor/PBM strategy, and specialty biopharmaceutical reimbursement.

The role's scope is particularly relevant to professionals with experience in complex reimbursement models, cell and gene therapies, CAR-T, advanced oncology products, and cross-functional pharmaceutical market access leadership.

Required qualifications

Extensive senior-level experience in pharmaceutical or biopharmaceutical market access.

- Experience leading commercial contracting strategies across major U.S. health systems and integrated delivery networks.

- Strong understanding of payor and Pharmacy Benefit Manager (PBM) relationships.

- Experience with complex reimbursement pathways for CAR-T, cell and gene therapies, or advanced oncology treatments.

- Knowledge of value-based contracting and innovative reimbursement arrangements.

- Experience collaborating with HEOR, Medical Affairs, and Corporate Pricing functions.

- Understanding of U.S. healthcare reimbursement policy, including IRA and Medicaid best-price considerations.

Preferred qualifications

- Extensive senior-level experience in pharmaceutical or biopharmaceutical market access.

- Experience leading commercial contracting strategies across major U.S. health systems and integrated delivery networks.

- Strong understanding of payor and Pharmacy Benefit Manager (PBM) relationships.

- Experience with complex reimbursement pathways for CAR-T, cell and gene therapies, or advanced oncology treatments.

- Knowledge of value-based contracting and innovative reimbursement arrangements.

- Experience collaborating with HEOR, Medical Affairs, and Corporate Pricing functions.

- Understanding of U.S. healthcare reimbursement policy, including IRA and Medicaid best-price considerations.

Compensation & benefits

The supplied confidential executive briefing indicates the following proposed compensation package:

Base salary range: $345,000–$415,000 USD.

Annual short-term incentive (STI): 40%–50% target performance bonus.

Long-term incentives: Annual executive stock grant / long-term incentive package with a stated target value of $250,000+.

Executive benefits include comprehensive health, dental and vision coverage, executive health screening, a deferred compensation plan, 401(k) matching contribution of 6%, car allowance, and full relocation support.

All compensation and benefit figures should be independently confirmed before being communicated as official employment terms.

Work arrangements

Arrangement: Full-time, Executive Leadership Position.

Location: United States – national market remit; physical office location not specified

The position carries national U.S. market responsibilities, involving engagement with major health systems, integrated delivery networks, and payor/PBM organisations.

Relocation support is indicated in the supplied executive briefing. Specific office attendance requirements, eligible work locations, domestic travel expectations, and remote-work arrangements require confirmation.

Reporting structure

Reporting line: Senior Vice President, U.S. Market Access / Commercial Leadership.

Department: U.S. Market Access / Health System Access & Commercial Contracting

Application instructions

This is being handled through the Westbridge Search executive recruitment process. Interested candidates should first communicate their interest to the Westbridge Search representative. Further information about the confidential review and application process will be provided directly to candidates who wish to proceed. Candidates should not submit a separate public application unless instructed to do so.

Independent analysis

The strongest alignment is the combination of her prior formulary strategy experience at UnitedHealthcare and Optum, her access leadership experience at Takeda, and her current U.S. Health System Access & Pricing leadership at Kite Pharma. Her stated expertise in cell and gene therapy reimbursement, PBM strategy, health-system contracting, and IRA/P&T policy provides a relevant connection to the position's commercial contracting and advanced oncology access responsibilities. The supplied assessment identifies this position as the highest-alignment option, with an internal fit score of 98/100. This is an advisory candidate assessment and should not be represented as an evaluation conducted by Johnson & Johnson.

Interested in this role?

Westbridge reviews role enquiries and responds with relevant information about the opportunity and its application process.

Ask about this role →

More opportunities

Loading roles…